• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) Product Image

Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)

  • Published: April 2013
  • Region: Global
  • 211 Pages
  • BioInformant
Strategies and techniques to profit from the global cord blood banking market

The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as within most developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.

This recently launched industry report "Capitalizing on Opportunities in Cord Blood Industry Growth" addresses this issue by strategically positioning cord blood banks to expand, profit, and outmanoeuvre the competition.

The report also reveals strategies for dominating the global cord blood banking industry, including tactics for global expansion, patterns in regional dominance, and methods for investing in the sector. A distinctive feature is a global survey of expectant parents who reveal their deepest fears, core expectations, and critical factors influencing buying decisions. It is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, READ MORE >

PART 1: Cord Blood Banking Industry - Market Overview & Outlook

I. History of Cord Blood Banking

A. Overview
B. Timeline of Critical Events

II. Likelihood of Needing a Stem Cell Transplant

A. Childhood Probability
B. Full Life-Span Analysis

III. Current, Future, and Projected Conditions Treatable with Cord Blood Transplant

A. Categories of Disease Treatable With Cord Blood Transplant
B. Existing Conditions
C. Therapies in Clinical Trial
1. Human Trials
2. Laboratory Trials
D. Projected Conditions

IV. Cord Blood vs. Bone Marrow and Peripheral Blood, as a Source of Hematopoietic Stem Cells for Transplant

A. Sources of Hematopoietic Stem Cells
B. Global Survey on Use of Hematopoietic Stem Cells in Transplantation (2010 Baseline)
C. Worldwide Statistics on Hematopoietic Stem Cell Transplantation (2013 Data)

V. Cord Blood Banking – Storage Options

A. U.S. Private Banks
B. U.S. Public Banks
1. Free Programs for Families in Medical Need
2. Mail-in Donation (Public) Cord Blood Banks
C. International Summary and Comparison
1. Top 15 Countries for Cord Blood Banking
2. Number of Private Cord Blood Banks by International Region
D. Breakdown of Canadian Cord Blood Banks – Public vs. Private / AABB Accredited vs. Non- Accredited
E. International Private and Public Cord Blood Banks by Region
1. South America
2. Asia
3. Africa
F. List of International Public Cord Blood Banks (Alphabetical by Country)
G. Worldwide List of AABB Accredited Cord Blood Facilities

PART 2: Expansion and Growth – Trailing 12-Month Analysis & Future Projections

I. Fast-Growth vs. Flat-Growth – Bimodal Distribution

II. Growth Rate

III. Revenue

A. Flat-line Growth Companies (< 3% per year)
B. Substantive Revenue Growth Companies (25% or more per year)

IV. Industry Conditions

A. North America
1. Canada
2. Mexico
3. United States
B. South America
1. Brazil
2. Chile
3. Colombia
C. Asia
1. China
2. India
3. Japan
4. Korea
5. Malaysia
6. Singapore
7. Taiwan
8. Thailand
D. Australia/New Zealand
E. Europe
1. France
2. Germany/Austria
3. Italy
4. Netherlands
5. Poland
6. Russia
7. Spain
8. United Kingdom

V. Trends

A. Rates of Worldwide Cord Blood Storage (Units per Year)
B. Medical Society Opinions of Cord Blood Banking
C. Cord Blood Scientific Publication Rates
D. Cord Blood Research Funding Levels (Grant Analysis)
1. U.S. Grant Funding Analysis
2. Worldwide Grant Funding Analysis
E. Cord Blood Patent Breakdown
F. Rates of Cord Blood Research Product Development
G. Top Countries for Cord Blood Research
H. Cord Blood Conferences & Events

VI. Cord Tissue Storage

A. Overview of Cord Blood Storage vs. Cord Tissue Storage
B. Pricing of Cord Tissue Storage
C. Clinical Trials – Cord Blood vs. Cord Tissue
D. Market Penetration of Cord Tissue Storage

VII. Barriers to Entering the Cord Blood Market

A. Accreditation
1. Types of Accreditation
2. AABB Overview
3. ABB Accredited Cord Blood Banks
4. Current Conditions
B. Security requirements
C. Laboratory and Storage Requirements
D. Cord Blood Banking Legislation
1. United States
2. European Union

VIII. Leveraging Novel Tactics for Substantive Revenue Growth

A. Strategic Collaborations
1. Regional Hospitals and Birthing Centers a. Public Banking System
b. Private Banking System
2. Broad-Spectrum Collaborations
B. Careful Selection of Region
C. Establishing Credentials - Indicators of Reputability (Accreditation, Licensure, Transplant Track Records)
D. Merger and Acquisition Potential
E. Multi-National Marketing Framework
F. Parental Referral Programs
G. Effective Communication of Cord Blood Banking Services
H. Rapid Integration of New Technologies
I. Low-Cost Operating Environment
J. Government Support and Affiliation
K. Utilizing Third-Party Cryogenic Storage Facilities
L. Capital Resources

IX. Comparing to the Competition – Setting Yourself Apart

A. Ten Largest Cord Blood Banks – Pricing and Characteristics Comparison
B. Cost Variation
1. Range of Pricing for U.S. Cord Blood Companies (1-100th percentiles)
a. U.S. Cord Blood Banking Price Range (1-100th percentiles)
b. LOWEST U.S. Pricing c. HIGHEST U.S. Pricing
d. Average U.S. Cord Blood Costs (25-75thpercentiles)
e. Median Cost of Storage (50thpercentile)
2. Range of Pricing for Canadian Cord Blood Companies (1-100th percentiles)
a. Canadian Fee Price Range (1-100th percentiles)
b. LOWEST Canadian Pricing c. HIGHEST Canadian Pricing
d. Average Canadian Cord Blood Storage Costs (25-75thpercentiles)
e. Median Canadian Cost of Storage (50thpercentile)
C. Technical Variables
1. Vapor-Phase Storage vs. Liquid-Phase Storage
2. Cryo-bags vs. Cryo-vials
3. Pentastarch vs. Hetastarch
4. Computer Controlled vs. Manual Rate Freezing
5. Whole Sample vs. Volume Reduction
6. High-Control vs. Low-Control Aseptic Processing
D. Corporate Variables
1. Corporate Stability
2. Scientific Expertise

PART 3: Parent Survey - Continuing to Grow by Listening to Expectant Parents

I. Global Expectant Parent Survey (2013)
A. Characteristics of Survey Respondent Population
B. Survey Results - Respondents who Banked Cord Blood Privately
C. Survey Results - Respondents who Banked Cord Blood Publicly
D. Survey Results - Respondents who Did Not Bank Cord Blood
E. Survey Results - All Respondents

II. Summary of Conclusions

APPENDICES

APPENDIX A – Existing Conditions Treatable with Cord Blood Transplant
APPENDIX B – U.S. List of Cord Blood Banks, by Type of Bank (Private, Hybrid, or Public)
APPENDIX C – Global List of Cord Blood Banks, 2013
APPENDIX D – Accreditation Standards by U.S Cord Blood Bank, Public and Private
APPENDIX E – AABB Accredited Cord Blood Banks Worldwide, 2013
APPENDIX F – Cord Blood Stem Cell Legislation by U.S. State
APPENDIX G – Case Study: Virgin Health Bank

PART 1: Global Cord Blood Banking Industry - Market Overview & Outlook

As of 2013, the cord blood banking industry is one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide; today there are 485. This represents a 21-fold increase (2,100%) in industry growth, over only an eight year period.

Furthermore, stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. Cord blood banks now exist in nearly every developed country, as well as within several developing nations.

However, there is still significant variation within the industry. First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a diverse geographic region. There is also variation in the services offered by private cord blood banks, with cord tissue storage emerging as a commercial service in 2008, when a Taiwanese company, HealthBanks Biotech Company Ltd., began offering the service. Since then, the trend of cord tissue storage has had a significant impact on the cord blood banking industry, as 23 companies now offer private cord tissue storage services worldwide. Finally, there is significant variation in the quality, pricing, and guarantees promised by cord blood banks.

This section of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. It is a roadmap of where the cord blood banking industry has been, what has shaped it, and where it is going. With an understanding of these relevant market conditions, the subsequent sections of this report become “rooted” and relevant.

PART 2: Expansion & Growth – Trailing 12-Month Analysis and Future Projections

While the last section investigated where the global cord blood banking industry has been and what has shaped it, this section explores where it is now and what you can anticipate for the near-term future. It provides a detailed assessment of current market conditions and near-term projections.

Regional similarities and differences are presented, as following global trends in cord blood banking provides a strategic advantage. Due to varying regulatory, cultural, technical, and medical differences between geographic regions of the world, successful trends that emerge in one region can often be modeled in another.

This section also explores key industry trends for the global cord blood banking industry, including rates of cord blood storage, scientific publication rates, grant rates, patent rates, and much more. Barriers to entering the marketplace are also considered, as are novel tactics for driving company growth. Finally, differences in pricing, technical variables, and corporate variables are explored, allowing cord blood banks to understand how they compare relative to the competition.

Furthermore, over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood industry and revenue growth at existing operations. Deeper analysis reveals that most existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum). To guide industry competitors, this section of the report considers the questions:

- What factors are causing a substantial number of new cord blood banks to open up business?

- What will be the effect of these new entrants to the cord blood banking industry for existing competitors?

- How can existing competitors maintain a position of dominance in the industry among this trend?

While a similar bimodal distribution existed in the prior 12 month period (trailing 12 to 24 months), the peaks have continued to separate over the past 12 months, with the average flat-growth company staying stagnant and the average fast- growth company substantially increasing its per annum growth rate. This trend indicates an increasing shift in dominance toward fast-growth companies, which begs the questions:

- What are the differences among the cord blood banks that are experiencing flat-line growth, versus those that have substantively building revenue?

- Why are the fast-growth companies continuing to increase their dominance relative to the flat growth companies?

In summary, this section is dedicated to identifying, quantifying, and extrapolating global industry trends, for the purpose of giving meaningful projections for the future.

It is your guide to understanding expansion and growth within the global cord blood banking industry.

PART 3: Parent Survey – Continuing to Grow by Listening to Expectant Parents

To recap, the first section of the report established where the cord blood banking industry has been and what has shaped it. The second section explores where it is now and what you should anticipate for the near-term future, providing a detailed assessment of current market conditions and near-term projections. This final section of the report is now your roadmap to the future. It is your guide to taking strategic action and controlling your competitive position as a global cord blood bank.

This section contains findings from a detailed parent survey that reveals how expectant parents worldwide learn about cord blood banking, think about the process, and make key decisions. This survey is your insight into the mind of your prospective clients. Use it to claim a powerful control of your ability to sell your services more effectively.

You can use the findings revealed here to:

- Alter the way you position your products

- Understand why parents bank publicly, privately, or not at all

- Communicate successfully with parents

- Effectively educate parents

- Prioritize your advertising budget

- Sell your services more effectively

In summary, this section is your guide to growing, expanding, and profiting, by listening to the needs of your clients – expectant parents.

About the Expanded 2013 Version:

This expanded 2013 version of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. Readers of the report are taken through the process of understanding where the cord blood banking industry has been and what has shaped it, where it is now and what should be anticipated for the near-term future. This expanded 2013 version of the report reveals up-to-date strategies for dominating the cord blood banking industry, investigates tactics for global expansion, and identifies patterns in regional dominance– which is particularly valuable because there has been rapid industry growth within specific regions of the world.

Finally, it gives perspective into the experience and decision-making process of prospective clients, delivering an insider's understanding of how to more effectively communicate and position cord blood banking services to expectant parents: it includes a 2013 Global Survey of Expectant Parents that explores how cord blood banks can best communicate with and market services to potential clients and features an extensive Appendix. The Appendix includes a full list of "Existing Conditions Treatable with Cord Blood Transplant," a "Global List of Cord Blood Banks, 2013," an overview of "AABB Accredited Cord Blood Banks Worldwide, 2013,” and more.

The report is designed to guide decision-making of global cord blood banks, as well as to advise companies investing in the cord blood banking sector, including venture capital funds and private investors. It differs from the "Complete 2012-13 U.S. Cord Blood Banking Industry Report" (details here) in that it is a strategic overview of how to profit from the global cord blood banking market, rather than from the U.S. markets alone.

In summary, this industry report is a strategic overview of how to profit from global growth in cord blood banking and provides insights necessary to take decisive, strategic action.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos